Testing effectiveness (Phase 2)Ended earlyNCT04964960What this trial is testingPembro+Chemo in Brain MetsWho this might be right forLung CancerLung Cancer MetastaticBrain Cancer+1 more John L. Villano, MD, PhD 3
Testing effectiveness (Phase 2)Study completedNCT01380782What this trial is testingBIBF 1120 for Recurrent High-Grade GliomasWho this might be right forGlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more Patrick Y. Wen, MD 37
Not applicableLooking for participantsNCT03726359What this trial is testingPhase I Study of Fractionated Stereotactic Radiation TherapyWho this might be right forBrain Metastases Albert Einstein College of Medicine 43
Not applicableUnknownNCT05630313What this trial is testingGene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in BrazilWho this might be right forVaccine-induced Thrombotic Thrombocytopenia SyndromeGuillain-Barre SyndromeAcute Disseminated Encephalomyelitis+1 more The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 100
Not applicableStudy completedNCT05203523What this trial is testingInvestigational Dementia Treatment StudyWho this might be right forDementia, Mild University of Manitoba 73
Testing effectiveness (Phase 2)UnknownNCT01593488What this trial is testingLiposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in ChildrenWho this might be right forAcute Lymphoblastic Leukemia National Cancer Institute, Naples 31
Large-scale testing (Phase 3)Looking for participantsNCT07481786What this trial is testingBevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain MetastasesWho this might be right forLung AdenocarcinomaBrain MetastasesRadiotherapy, Intensity-Modulated+2 more Sun Yat-sen University 220
Not applicableLooking for participantsNCT05474573What this trial is testingConcurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and MetastasesWho this might be right forGlioma, MalignantMetastases to Brain Sklifosovsky Institute of Emergency Care 52
Early research (Phase 1)Not Yet RecruitingNCT07739017What this trial is testingOLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaWho this might be right forRecurrent GlioblastomaNewly Diagnosed MGMT Unmethylated Glioblastoma Olivia Newton-John Cancer Research Institute 54
Very early researchEnded earlyNCT03927274What this trial is testingIntratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV GliomaWho this might be right forGlioma of Brain H. Lee Moffitt Cancer Center and Research Institute 3
Not applicableStudy completedNCT03798418What this trial is testingSarcopenia and Risk of Falls in Patients With Major Chronic DiseasesWho this might be right forStrokeOsteoporosisChronic Kidney Diseases+1 more Changhua Christian Hospital 186
Early research (Phase 1)Active Not RecruitingNCT03478462What this trial is testingDose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasWho this might be right forPediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more Cellectar Biosciences, Inc. 30
Not applicableWithdrawnNCT06127810What this trial is testingMRI Gadopiclenol Enhanced Imaging of CNS TumorsWho this might be right forImage Medical University of South Carolina
Not applicableEnded earlyNCT01281982What this trial is testing(11C)dLop as a Marker of P-Glycoprotein Function in Patients With GliomasWho this might be right forLow Grade GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06462079What this trial is testingSacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain MetastasesWho this might be right forBrain Metastasis Guangzhou Medical University 43
Early research (Phase 1)Looking for participantsNCT07652762What this trial is testingIN10018 in Combination With Dalpiciclib for Progressive MeningiomasWho this might be right forMeningiomaCDK4/6 Inhibitor Capital Medical University 24
Testing effectiveness (Phase 2)Ended earlyNCT01857752What this trial is testingPhase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From GuatemalaWho this might be right forRetinoblastoma Stanford University 3
Testing effectiveness (Phase 2)WithdrawnNCT02072252What this trial is testingMobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to MenWho this might be right forDepressive SymptomsAnxiety Generalized Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00389584What this trial is testingIrinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid TumorsWho this might be right forBrain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in Adults+4 more University of California, Davis 30
Large-scale testing (Phase 3)UnknownNCT03025893What this trial is testingA Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma MultiformeWho this might be right forGlioblastoma MultiformeGlioblastoma, AdultGlioblastoma+2 more Amsterdam UMC, location VUmc 100